欢迎来到天天文库
浏览记录
ID:34878928
大小:2.17 MB
页数:37页
时间:2019-03-13
《开肺汤加减联合热毒宁治疗小儿支原体肺炎(风热闭肺型)的临床研究》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、学校代号10199学号20125126100硕士学位论文开肺汤加减联合热毒宁治疗小儿支原体肺炎(风热闭肺型)的临床研究Theclinicalresearchofthetreatmentforchildrenwithmycoplasmapneumonia(windhotlungclosedtype)usingKaifeiDecoctioncombinedhotpoisoninjection学位申请人荀昭凤导师姓名职称冯晓纯教授专业名称中西医结合临床研究方向小儿呼吸系统与消化系统的防治研究培养方式全日制申请学位类型专业学位论文提交日期2015年4月分类号密级UDC编号硕±
2、学位论文开肺汤加减联合热毒宁治巧小儿支原体肺炎(风热闲肺型)的床研究Theclinicalresearchof.thetreatmentforchildrenwithmcoplasmaneumoniaypwindhotlunclosedteusinKaifei(gyp)gDecoctioncombinedhotoisoninectionpj荀昭凤指导教师姓名:冯晓纯教授(长春中医药大学)申请学位级别:硕±专业名称:中西医结合临床研究方向:小儿呼吸系统与消化系统的防治研究论文提交日期:2015年4月论
3、文答辩日期:2015年6月学位授予单位:长春中医药大学提交确认:作者签名^日召巧,导师签名:长春中屋药大学学位论文原创性声明本人郑重声明,独立进行研究工作所取得的成果。:所呈交的学位论文,是个人在导师的指导下除文中己经特别加u注明引用的内容外,本论文不含任何其他个人或集体已经发表或撰写过的作品,均已在文中U明确方式标明并致谢成果。对本文的研究做出重要贡献的个人和集体。本人完全意识到本声明的法律结果由本人承担。学位论文作者签名少。年占月日关于学位论文知识产权归属的声明本人郑重声明:所呈交的学位论文,是本人在导师指导下自选课题或导师承担的国家立项资
4、助一的计划课题的部分,知识产权归属,系本人在导师巧导和资助下独立进行祝究工作所取得的成果一权为长春中医药大学和本人导师所有。特此声明,本声明的切法律责任由本人承担。论文作者巧《^白胃^指导教师簇名年6月H/互八关于学位论文使用授权的声明本人完全了解长春中医药大学有关保留使用学位论文的规定,同意学校保留并向有关机构送交论文的复印件和电子版,允许被查阅和借阅。本人授权长春中医药大学可U将本学位论文的全部或部分内容编人有关数据库进行检索可W采用影印、缩巧或其他复印手段保存和汇编本学位论文。,(保密论文在解密后应遵守此规定)J少论义作者溶《若日吕凤、指
5、导教师察么者ChLo年月日/王(长春中医药大学2015届硕士学位论文目录目录中文摘要·······························································································1英文摘要·······························································································2英文缩略语····················································
6、········································3前言·······························································································4文献综述·······························································································5一中医学研究进展··················································
7、······························51中医对本病的论述··············································································52中医有关支原体肺炎病因病机探讨··························································63辨证分型···················
此文档下载收益归作者所有